Investment crowdfunding platform OurCrowd was the lead investor a $5.1 million funding round for DarioHealth Corp. (NASDAQ:DRIO).  OurCrowd’s funding came via their dedicated digital health fund Qure which invested $2.5 million of the $5.1 million total with $2 million of gross proceeds being subject to shareholder approval per Nasdaq rules. OurCrowd Qure was granted two board seats, which will be selected and announced at a later date.  Existing investors also participated in the funding round.

DarioHealth is described as a leader in digital health self-management solutions. The company delivers the ability to combine and analyze consumer health data to personalize treatment with its smart diabetes management solution.

Read more on Crowdfund Insider here.